Journal Article10.1016/S0002-9394(14)72141-5
Trimethoprim-sulfamethoxazole (co-trimoxazole) for the prevention of relapses of Wegener's granulomatosis
250
TL;DR: Treatment with co-trimoxazole reduces the incidence of relapses in patients with Wegener's granulomatosis in remission and is identified as an independent factor associated with prolonged disease-free survival and a positive antineutrophil cytoplasmic antibody test at the start of treatment as a risk factor for relapse.
read more
About: This article is published in American Journal of Ophthalmology. The article was published on 01 Oct 1996. The article focuses on the topics: Trimethoprim & Sulfamethoxazole.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
EULAR Recommendations for the management of primary small and medium vessel vasculitis
Chetan Mukhtyar,Loïc Guillevin,Maria C. Cid,Bhaskar Dasgupta,K de Groot,Wolfgang L. Gross,Thomas H. Hauser,B Hellmich,David Jayne,Cees G. M. Kallenberg,Peter A. Merkel,Heiner Raspe,Carlo Salvarani,Dgi Scott,Coen A. Stegeman,Richard A. Watts,Kerstin Westman,James Witter,Halil Yazici,Raashid Luqmani +19 more
TL;DR: On the basis of evidence and expert consensus, recommendations have been made for the evaluation, investigation, treatment and monitoring of patients with small and medium vessel vasculitis for use in everyday clinical practice.
KDIGO Clinical Practice Guideline for Glomerulonephritis
Kai-Uwe Eckardt,Bertram L. Kasiske +1 more
- 01 Jan 2012
TL;DR: This chapter discusses general principles in the management of glomerular disease, as well as methods for guideline development and examples of successful implementation of these principles.
1K
EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis
Bernhard Hellmich,Oliver Flossmann,Wolfgang L. Gross,Paul A. Bacon,Jan Willem Cohen-Tervaert,Loïc Guillevin,David Jayne,Alfred Mahr,Peter A. Merkel,Heiner Raspe,David G. I. Scott,James Witter,Hasan Yazici,Raashid Luqmani +13 more
TL;DR: Recommendations for conducting clinical trials in AAV deal with the following areas related to clinical studies of vasculitis: definitions of disease, activity states, outcome measures, eligibility criteria, trial design including relevant end points, and biomarkers.
Molecular mimicry in pauci-immune focal necrotizing glomerulonephritis
Renate Kain,Markus Exner,Ricarda Brandes,Reinhard Ziebermayr,Reinhard Ziebermayr,Dawn Cunningham,Carol A. Alderson,Agnes Davidovits,Ingrid Raab,Renate Jahn,Renate Jahn,Oliver Ashour,Susanne Spitzauer,Gere Sunder-Plassmann,Minoru Fukuda,Per Klemm,Andrew J. Rees,Andrew J. Rees,Dontscho Kerjaschki +18 more
TL;DR: FimH-triggered autoimmunity to LAMP-2 provides a previously undescribed clinically relevant molecular mechanism for the development of pauci-immune FNGN.
460
Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis: a systematic review by the European League Against Rheumatism systemic vasculitis task force.
Chetan Mukhtyar,Oliver Flossmann,B Hellmich,P. A. Bacon,Maria C. Cid,Jan Willem Cohen-Tervaert,Wolfgang L. Gross,Loïc Guillevin,D. R. W. Jayne,Alfred Mahr,Peter A. Merkel,Heiner Raspe,Dgi Scott,James Witter,Halil Yazici,Raashid Luqmani +15 more
TL;DR: A systematic literature review as a background to the European League Against Rheumatism recommendations for conducting clinical trials in anti-neutrophil cytoplasm antibody associated vasculitis (AAV) found methodological variations between studies highlight the need for a consensus on terminology and definitions for future conduct of clinical studies in AAV.
434
References
EULAR Recommendations for the management of primary small and medium vessel vasculitis
Chetan Mukhtyar,Loïc Guillevin,Maria C. Cid,Bhaskar Dasgupta,K de Groot,Wolfgang L. Gross,Thomas H. Hauser,B Hellmich,David Jayne,Cees G. M. Kallenberg,Peter A. Merkel,Heiner Raspe,Carlo Salvarani,Dgi Scott,Coen A. Stegeman,Richard A. Watts,Kerstin Westman,James Witter,Halil Yazici,Raashid Luqmani +19 more
TL;DR: On the basis of evidence and expert consensus, recommendations have been made for the evaluation, investigation, treatment and monitoring of patients with small and medium vessel vasculitis for use in everyday clinical practice.
KDIGO Clinical Practice Guideline for Glomerulonephritis
Kai-Uwe Eckardt,Bertram L. Kasiske +1 more
- 01 Jan 2012
TL;DR: This chapter discusses general principles in the management of glomerular disease, as well as methods for guideline development and examples of successful implementation of these principles.
1K
EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis
Bernhard Hellmich,Oliver Flossmann,Wolfgang L. Gross,Paul A. Bacon,Jan Willem Cohen-Tervaert,Loïc Guillevin,David Jayne,Alfred Mahr,Peter A. Merkel,Heiner Raspe,David G. I. Scott,James Witter,Hasan Yazici,Raashid Luqmani +13 more
TL;DR: Recommendations for conducting clinical trials in AAV deal with the following areas related to clinical studies of vasculitis: definitions of disease, activity states, outcome measures, eligibility criteria, trial design including relevant end points, and biomarkers.
Molecular mimicry in pauci-immune focal necrotizing glomerulonephritis
Renate Kain,Markus Exner,Ricarda Brandes,Reinhard Ziebermayr,Reinhard Ziebermayr,Dawn Cunningham,Carol A. Alderson,Agnes Davidovits,Ingrid Raab,Renate Jahn,Renate Jahn,Oliver Ashour,Susanne Spitzauer,Gere Sunder-Plassmann,Minoru Fukuda,Per Klemm,Andrew J. Rees,Andrew J. Rees,Dontscho Kerjaschki +18 more
TL;DR: FimH-triggered autoimmunity to LAMP-2 provides a previously undescribed clinically relevant molecular mechanism for the development of pauci-immune FNGN.
460
Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis: a systematic review by the European League Against Rheumatism systemic vasculitis task force.
Chetan Mukhtyar,Oliver Flossmann,B Hellmich,P. A. Bacon,Maria C. Cid,Jan Willem Cohen-Tervaert,Wolfgang L. Gross,Loïc Guillevin,D. R. W. Jayne,Alfred Mahr,Peter A. Merkel,Heiner Raspe,Dgi Scott,James Witter,Halil Yazici,Raashid Luqmani +15 more
TL;DR: A systematic literature review as a background to the European League Against Rheumatism recommendations for conducting clinical trials in anti-neutrophil cytoplasm antibody associated vasculitis (AAV) found methodological variations between studies highlight the need for a consensus on terminology and definitions for future conduct of clinical studies in AAV.
434